Atrial Fibrillation Amplifies Heart Failure Risk in Anthracycline Treated Cancer Patients: Stacking Risk Factors in the Vulnerable

Am J Cardiol. 2024 May 1:218:121-122. doi: 10.1016/j.amjcard.2024.02.017. Epub 2024 Mar 2.

Authors

Leonard Ilkhanoff¹, Brett Atwater², Ana Barac³

Affiliations

¹ Inova Schar Heart and Vascular, Division of Cardiology, Section of Electrophysiology, Falls Church, Virginia. Electronic address: [email protected].
² Inova Schar Heart and Vascular, Division of Cardiology, Section of Electrophysiology, Falls Church, Virginia.
³ Inova Schar Cancer, Division of Cardiology, Falls Church, Virginia.

PMID: 38438005
DOI: 10.1016/j.amjcard.2024.02.017

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anthracyclines
Atrial Fibrillation*
Heart Failure*
Humans
Neoplasms*
Risk Factors

Substances

Anthracyclines